Transgenic Animal Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product (Gene Gun, PCR, Microinjections, Others), By PCR (Real-Time PCR, Digital PCR Systems, Others), By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others), By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others), By Model Organisms (Mice, Rabbit, Cow, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others), By Company, and By Region
The global transgenic animal market is anticipated to observe an impressive growth during the forecast period, 2023-2027. The major factors include increasing consumption of animal-derived protein and dairy products and rise in R&D activities. A transgenic animal is one who's genes are modified to improve both quality and quantity of food demand and also help to understand gene disease. The other factors supporting the market's growth are rise various diseases, advancement in techniques, and growing awareness. Additionally, rising healthcare expenditure and implementation of the animal welfare regulations are driving the growth of the market in upcoming years.
Increasing Consumption of Animal-Derived Protein and Dairy Products
As protein and calcium plays a vital role in nutrition, the consumption of meat and meat products such as dairy products, eggs, beef, and chicken are increasing, which surge the market growth in foreseen years. For instance, genetically modified poultry, such as broilers, have high number of proteins which are easily digestible. Additionally, rapid urbanization and increase in population across the globe are bolstering the market growth. Owing to the increase in animal derived protein supplements and food products, the need for transgenic animals is also rising. Therefore, all these factors are propelling the growth of the transgenic animal market, globally. In 2015, a study by Meat and Livestock in Australia revealed that genetically modified cows can produce more milk and are less susceptible to cattle diseases.
Wide Applications of Transgenic Animals
Transgenic animals have numerous applications in various fields such as agriculture, medical and industrial sectors. They are used to develop new and improved strains of livestock and as model organisms. Development of transgenic farm animals are allowing more flexibility in direct genetic manipulation of livestock. With ever-growing world population and changing climate conditions, such efficient means of increasing food production are needed. In addition, transgenic animals are specifically designed to study the genes in order to develop a cure for the diseases such as Alzheimer’s and cancer. For instance, in 2020, Merck Animal Health along with Automazioni VX, Inc. (US) signed an agreement aiming to Innoject Pro, a newly designed subcutaneous chick vaccination technology. The technology will be utilized by coupling with Merck Animal Health’s Innovax range of vaccines, which aids for protection against infectious diseases.
Increasing awareness and R&D Initiatives
Various R&D initiatives and awareness programs are initiated by the governments of the respective countries, which is bolstering the growth of the transgenic market. As per a publication by the British Nutrition Foundation 2018, genetically modified cows were anticipated to produce milk without allergy-producing protein, which will make the product apt for lactose-intolerant people. As per the National Institute of Health, in 2017, approximately 8% of the population in the U.K. was suffering from lactose intolerance. Thus, the modifications are likely to provide newer prospects for animal genetics in the upcoming years. Furthermore, the rising initiative to educate on transgenic animal is further anticipated to drive the growth of this market.
Market Segmentation
The global transgenic animal market is segmented into product, PCR, technique, application, model organism, end user and company. Based on product, the market is divided into gene gun, PCR, microinjections, and others. Based on PCR, the market is divided into real-time PCR, digital PCR System, and others. Based on technique, the market is segmented into DNA microinjection, embryonic stem cell-mediated gene transfer, retrovirus-mediated gene transfer, and others. Based on application, the market is segmented into recombinant human proteins, monoclonal antibodies, xenotransplantation, and others. Based on model organisms, the market is segmented into mice, rabbit, cow, and others. Based on end user, the market is segmented into biotechnology & pharmaceutical companies, academic & research organizations, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising animal-based protein food and growing occurrence of diseases in the country.
Market Players Merck & Co., Inc., C.H. Boehringer Sohn Ko. KG, Randox Laboratories Limited, Zoetis, Inc., Virbac SA, Elanco Animal Health Inc., Biogйnesis Bagу SA, Santa Cruz Biotechnology, Inc, Idexx Laboratories, Inc., and Innovative Diagnostics (IDVet) are some of the leading companies operating in the market.
Report Scope:
In this report, global transgenic animal market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Transgenic Animal Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Increasing Consumption of Animal-Derived Protein and Dairy Products
As protein and calcium plays a vital role in nutrition, the consumption of meat and meat products such as dairy products, eggs, beef, and chicken are increasing, which surge the market growth in foreseen years. For instance, genetically modified poultry, such as broilers, have high number of proteins which are easily digestible. Additionally, rapid urbanization and increase in population across the globe are bolstering the market growth. Owing to the increase in animal derived protein supplements and food products, the need for transgenic animals is also rising. Therefore, all these factors are propelling the growth of the transgenic animal market, globally. In 2015, a study by Meat and Livestock in Australia revealed that genetically modified cows can produce more milk and are less susceptible to cattle diseases.
Wide Applications of Transgenic Animals
Transgenic animals have numerous applications in various fields such as agriculture, medical and industrial sectors. They are used to develop new and improved strains of livestock and as model organisms. Development of transgenic farm animals are allowing more flexibility in direct genetic manipulation of livestock. With ever-growing world population and changing climate conditions, such efficient means of increasing food production are needed. In addition, transgenic animals are specifically designed to study the genes in order to develop a cure for the diseases such as Alzheimer’s and cancer. For instance, in 2020, Merck Animal Health along with Automazioni VX, Inc. (US) signed an agreement aiming to Innoject Pro, a newly designed subcutaneous chick vaccination technology. The technology will be utilized by coupling with Merck Animal Health’s Innovax range of vaccines, which aids for protection against infectious diseases.
Increasing awareness and R&D Initiatives
Various R&D initiatives and awareness programs are initiated by the governments of the respective countries, which is bolstering the growth of the transgenic market. As per a publication by the British Nutrition Foundation 2018, genetically modified cows were anticipated to produce milk without allergy-producing protein, which will make the product apt for lactose-intolerant people. As per the National Institute of Health, in 2017, approximately 8% of the population in the U.K. was suffering from lactose intolerance. Thus, the modifications are likely to provide newer prospects for animal genetics in the upcoming years. Furthermore, the rising initiative to educate on transgenic animal is further anticipated to drive the growth of this market.
Market Segmentation
The global transgenic animal market is segmented into product, PCR, technique, application, model organism, end user and company. Based on product, the market is divided into gene gun, PCR, microinjections, and others. Based on PCR, the market is divided into real-time PCR, digital PCR System, and others. Based on technique, the market is segmented into DNA microinjection, embryonic stem cell-mediated gene transfer, retrovirus-mediated gene transfer, and others. Based on application, the market is segmented into recombinant human proteins, monoclonal antibodies, xenotransplantation, and others. Based on model organisms, the market is segmented into mice, rabbit, cow, and others. Based on end user, the market is segmented into biotechnology & pharmaceutical companies, academic & research organizations, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising animal-based protein food and growing occurrence of diseases in the country.
Market Players Merck & Co., Inc., C.H. Boehringer Sohn Ko. KG, Randox Laboratories Limited, Zoetis, Inc., Virbac SA, Elanco Animal Health Inc., Biogйnesis Bagу SA, Santa Cruz Biotechnology, Inc, Idexx Laboratories, Inc., and Innovative Diagnostics (IDVet) are some of the leading companies operating in the market.
Report Scope:
In this report, global transgenic animal market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Transgenic Animal Market, By Product:
- Gene Gun
- PCR
- Real-Time PCR
- Digital PCR Systems
- Others
- Microinjections
- Others
- Transgenic Animal Market, By Technique:
- DNA Microinjection
- Embryonic Stem Cell-Mediated Gene Transfer
- Retrovirus-Mediated Gene Transfer
- Others
- Transgenic Animal Market, By Application:
- Recombinant Human Proteins
- Monoclonal Antibodies
- Xenotransplantation
- Others
- Transgenic Animal Market, By Model Organisms:
- Mice
- Rabbit
- Cow
- Others
- Transgenic Animal Market, By End User:
- Biotechnology & Pharmaceutical Companies
- Academic & Research Organizations
- Others
- Transgenic Animal Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in Transgenic Animal Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON GLOBAL TRANSGENIC ANIMAL MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
6. CLINICAL TRIAL ANALYSIS
7. GLOBAL TRANSGENIC ANIMAL MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
7.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
7.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
7.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
7.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
7.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
7.2.6. By Company (2021)
7.2.7. By Region
7.3. Product Market Map
8. NORTH AMERICA TRANSGENIC ANIMAL MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
8.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
8.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
8.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
8.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
8.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
8.2.6. By Country
8.3. North America: Country Analysis
8.3.1. United States Transgenic Animal Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Technique
8.3.1.2.3. By Application
8.3.1.2.4. By Model Organisms
8.3.1.2.5. By End User
8.3.2. Mexico Transgenic Animal Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Technique
8.3.2.2.3. By Application
8.3.2.2.4. By Model Organisms
8.3.2.2.5. By End User
8.3.3. Canada Transgenic Animal Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Technique
8.3.3.2.3. By Application
8.3.3.2.4. By Model Organisms
8.3.3.2.5. By End User
9. EUROPE TRANSGENIC ANIMAL MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
9.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
9.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
9.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
9.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
9.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
9.2.6. By Country
9.3. Europe: Country Analysis
9.3.1. France Transgenic Animal Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Technique
9.3.1.2.3. By Application
9.3.1.2.4. By Model Organisms
9.3.1.2.5. By End User
9.3.2. Germany Transgenic Animal Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Technique
9.3.2.2.3. By Application
9.3.2.2.4. By Model Organisms
9.3.2.2.5. By End User
9.3.3. United Kingdom Transgenic Animal Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Technique
9.3.3.2.3. By Application
9.3.3.2.4. By Model Organisms
9.3.3.2.5. By End User
9.3.4. Italy Transgenic Animal Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Technique
9.3.4.2.3. By Application
9.3.4.2.4. By Model Organisms
9.3.4.2.5. By End User
9.3.5. Spain Transgenic Animal Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Technique
9.3.5.2.3. By Application
9.3.5.2.4. By Model Organisms
9.3.5.2.5. By End User
10. ASIA-PACIFIC TRANSGENIC ANIMAL MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
10.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
10.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
10.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
10.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
10.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
10.2.6. By Country
10.3. Asia-Pacific: Country Analysis
10.3.1. China Transgenic Animal Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Technique
10.3.1.2.3. By Application
10.3.1.2.4. By Model Organisms
10.3.1.2.5. By End User
10.3.2. India Transgenic Animal Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Technique
10.3.2.2.3. By Application
10.3.2.2.4. By Model Organisms
10.3.2.2.5. By End User
10.3.3. Japan Transgenic Animal Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Technique
10.3.3.2.3. By Application
10.3.3.2.4. By Model Organisms
10.3.3.2.5. By End User
10.3.4. South Korea Transgenic Animal Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product
10.3.4.2.2. By Technique
10.3.4.2.3. By Application
10.3.4.2.4. By Model Organisms
10.3.4.2.5. By End User
10.3.5. Australia Transgenic Animal Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Product
10.3.5.2.2. By Technique
10.3.5.2.3. By Application
10.3.5.2.4. By Model Organisms
10.3.5.2.5. By End User
10.3.6. Vietnam Transgenic Animal Market Outlook
10.3.6.1. Market Size & Forecast
10.3.6.1.1. By Value
10.3.6.2. Market Share & Forecast
10.3.6.2.1. By Product
10.3.6.2.2. By Technique
10.3.6.2.3. By Application
10.3.6.2.4. By Model Organisms
10.3.6.2.5. By End User
10.3.7. Indonesia Transgenic Animal Market Outlook
10.3.7.1. Market Size & Forecast
10.3.7.1.1. By Value
10.3.7.2. Market Share & Forecast
10.3.7.2.1. By Product
10.3.7.2.2. By Technique
10.3.7.2.3. By Application
10.3.7.2.4. By Model Organisms
10.3.7.2.5. By End User
10.3.8. Singapore Transgenic Animal Market Outlook
10.3.8.1. Market Size & Forecast
10.3.8.1.1. By Value
10.3.8.2. Market Share & Forecast
10.3.8.2.1. By Product
10.3.8.2.2. By Technique
10.3.8.2.3. By Application
10.3.8.2.4. By Model Organisms
10.3.8.2.5. By End User
11. SOUTH AMERICA TRANSGENIC ANIMAL MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
11.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
11.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
11.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
11.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
11.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
11.2.6. By Country
11.3. South America: Country Analysis
11.3.1. Brazil Transgenic Animal Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Technique
11.3.1.2.3. By Application
11.3.1.2.4. By Model Organisms
11.3.1.2.5. By End User
11.3.2. Argentina Transgenic Animal Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Technique
11.3.2.2.3. By Application
11.3.2.2.4. By Model Organisms
11.3.2.2.5. By End User
11.3.3. Colombia Transgenic Animal Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Technique
11.3.3.2.3. By Application
11.3.3.2.4. By Model Organisms
11.3.3.2.5. By End User
11.3.4. Chile Transgenic Animal Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product
11.3.4.2.2. By Technique
11.3.4.2.3. By Application
11.3.4.2.4. By Model Organisms
11.3.4.2.5. By End User
12. MIDDLE EAST AND AFRICA TRANSGENIC ANIMAL MARKET OUTLOOK
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
12.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
12.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
12.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
12.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
12.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
12.2.6. By Country
12.3. MEA: Country Analysis
12.3.1. South Africa Transgenic Animal Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1. By Product
12.3.1.2.2. By Technique
12.3.1.2.3. By Application
12.3.1.2.4. By Model Organisms
12.3.1.2.5. By End User
12.3.2. Saudi Arabia Transgenic Animal Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1. By Product
12.3.2.2.2. By Technique
12.3.2.2.3. By Application
12.3.2.2.4. By Model Organisms
12.3.2.2.5. By End User
12.3.3. UAE Transgenic Animal Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1. By Product
12.3.3.2.2. By Technique
12.3.3.2.3. By Application
12.3.3.2.4. By Model Organisms
12.3.3.2.5. By End User
12.3.4. Egypt Transgenic Animal Market Outlook
12.3.4.1. Market Size & Forecast
12.3.4.1.1. By Value
12.3.4.2. Market Share & Forecast
12.3.4.2.1. By Product
12.3.4.2.2. By Technique
12.3.4.2.3. By Application
12.3.4.2.4. By Model Organisms
12.3.4.2.5. By End User
12.3.5. Turkey Transgenic Animal Market Outlook
12.3.5.1. Market Size & Forecast
12.3.5.1.1. By Value
12.3.5.2. Market Share & Forecast
12.3.5.2.1. By Product
12.3.5.2.2. By Technique
12.3.5.2.3. By Application
12.3.5.2.4. By Model Organisms
12.3.5.2.5. By End User
13. MARKET DYNAMICS
13.1. Drivers
13.2. Challenges
14. MARKET TRENDS & DEVELOPMENTS
15. COMPETITIVE LANDSCAPE (INCLUSIVE OF SWOT ANALYSIS)
15.1. Merck & Co., Inc.
15.2. C.H. Boehringer Sohn Ko. KG
15.3. Randox Laboratories Limited
15.4. Zoetis, Inc.
15.5. Virbac SA
15.6. Elanco Animal Health Inc.
15.7. Biogйnesis Bagу SA
15.8. Santa Cruz Biotechnology, Inc
15.9. Idexx Laboratories, Inc.
15.10. Innovative Diagnostics (IDVet)
16. STRATEGIC RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON GLOBAL TRANSGENIC ANIMAL MARKET
4. EXECUTIVE SUMMARY
5. VOICE OF CUSTOMER
6. CLINICAL TRIAL ANALYSIS
7. GLOBAL TRANSGENIC ANIMAL MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
7.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
7.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
7.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
7.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
7.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
7.2.6. By Company (2021)
7.2.7. By Region
7.3. Product Market Map
8. NORTH AMERICA TRANSGENIC ANIMAL MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
8.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
8.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
8.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
8.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
8.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
8.2.6. By Country
8.3. North America: Country Analysis
8.3.1. United States Transgenic Animal Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Technique
8.3.1.2.3. By Application
8.3.1.2.4. By Model Organisms
8.3.1.2.5. By End User
8.3.2. Mexico Transgenic Animal Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Technique
8.3.2.2.3. By Application
8.3.2.2.4. By Model Organisms
8.3.2.2.5. By End User
8.3.3. Canada Transgenic Animal Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Technique
8.3.3.2.3. By Application
8.3.3.2.4. By Model Organisms
8.3.3.2.5. By End User
9. EUROPE TRANSGENIC ANIMAL MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
9.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
9.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
9.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
9.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
9.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
9.2.6. By Country
9.3. Europe: Country Analysis
9.3.1. France Transgenic Animal Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Technique
9.3.1.2.3. By Application
9.3.1.2.4. By Model Organisms
9.3.1.2.5. By End User
9.3.2. Germany Transgenic Animal Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Technique
9.3.2.2.3. By Application
9.3.2.2.4. By Model Organisms
9.3.2.2.5. By End User
9.3.3. United Kingdom Transgenic Animal Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Technique
9.3.3.2.3. By Application
9.3.3.2.4. By Model Organisms
9.3.3.2.5. By End User
9.3.4. Italy Transgenic Animal Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Technique
9.3.4.2.3. By Application
9.3.4.2.4. By Model Organisms
9.3.4.2.5. By End User
9.3.5. Spain Transgenic Animal Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Technique
9.3.5.2.3. By Application
9.3.5.2.4. By Model Organisms
9.3.5.2.5. By End User
10. ASIA-PACIFIC TRANSGENIC ANIMAL MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
10.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
10.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
10.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
10.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
10.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
10.2.6. By Country
10.3. Asia-Pacific: Country Analysis
10.3.1. China Transgenic Animal Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Technique
10.3.1.2.3. By Application
10.3.1.2.4. By Model Organisms
10.3.1.2.5. By End User
10.3.2. India Transgenic Animal Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Technique
10.3.2.2.3. By Application
10.3.2.2.4. By Model Organisms
10.3.2.2.5. By End User
10.3.3. Japan Transgenic Animal Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Technique
10.3.3.2.3. By Application
10.3.3.2.4. By Model Organisms
10.3.3.2.5. By End User
10.3.4. South Korea Transgenic Animal Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product
10.3.4.2.2. By Technique
10.3.4.2.3. By Application
10.3.4.2.4. By Model Organisms
10.3.4.2.5. By End User
10.3.5. Australia Transgenic Animal Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Product
10.3.5.2.2. By Technique
10.3.5.2.3. By Application
10.3.5.2.4. By Model Organisms
10.3.5.2.5. By End User
10.3.6. Vietnam Transgenic Animal Market Outlook
10.3.6.1. Market Size & Forecast
10.3.6.1.1. By Value
10.3.6.2. Market Share & Forecast
10.3.6.2.1. By Product
10.3.6.2.2. By Technique
10.3.6.2.3. By Application
10.3.6.2.4. By Model Organisms
10.3.6.2.5. By End User
10.3.7. Indonesia Transgenic Animal Market Outlook
10.3.7.1. Market Size & Forecast
10.3.7.1.1. By Value
10.3.7.2. Market Share & Forecast
10.3.7.2.1. By Product
10.3.7.2.2. By Technique
10.3.7.2.3. By Application
10.3.7.2.4. By Model Organisms
10.3.7.2.5. By End User
10.3.8. Singapore Transgenic Animal Market Outlook
10.3.8.1. Market Size & Forecast
10.3.8.1.1. By Value
10.3.8.2. Market Share & Forecast
10.3.8.2.1. By Product
10.3.8.2.2. By Technique
10.3.8.2.3. By Application
10.3.8.2.4. By Model Organisms
10.3.8.2.5. By End User
11. SOUTH AMERICA TRANSGENIC ANIMAL MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
11.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
11.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
11.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
11.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
11.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
11.2.6. By Country
11.3. South America: Country Analysis
11.3.1. Brazil Transgenic Animal Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Technique
11.3.1.2.3. By Application
11.3.1.2.4. By Model Organisms
11.3.1.2.5. By End User
11.3.2. Argentina Transgenic Animal Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Technique
11.3.2.2.3. By Application
11.3.2.2.4. By Model Organisms
11.3.2.2.5. By End User
11.3.3. Colombia Transgenic Animal Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Technique
11.3.3.2.3. By Application
11.3.3.2.4. By Model Organisms
11.3.3.2.5. By End User
11.3.4. Chile Transgenic Animal Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Product
11.3.4.2.2. By Technique
11.3.4.2.3. By Application
11.3.4.2.4. By Model Organisms
11.3.4.2.5. By End User
12. MIDDLE EAST AND AFRICA TRANSGENIC ANIMAL MARKET OUTLOOK
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Product (Gene Gun, PCR, Microinjections, Others)
12.2.1.1. By PCR (Real-Time PCR, Digital PCR Systems, Others)
12.2.2. By Technique (DNA Microinjection, Embryonic Stem Cell-Mediated Gene Transfer, Retrovirus-Mediated Gene Transfer and Others)
12.2.3. By Application (Recombinant Human Proteins, Monoclonal Antibodies, Xenotransplantation, Others)
12.2.4. By Model Organisms (Mice, Rabbit, Cow, Others)
12.2.5. By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Organizations, Others)
12.2.6. By Country
12.3. MEA: Country Analysis
12.3.1. South Africa Transgenic Animal Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1. By Product
12.3.1.2.2. By Technique
12.3.1.2.3. By Application
12.3.1.2.4. By Model Organisms
12.3.1.2.5. By End User
12.3.2. Saudi Arabia Transgenic Animal Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1. By Product
12.3.2.2.2. By Technique
12.3.2.2.3. By Application
12.3.2.2.4. By Model Organisms
12.3.2.2.5. By End User
12.3.3. UAE Transgenic Animal Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1. By Product
12.3.3.2.2. By Technique
12.3.3.2.3. By Application
12.3.3.2.4. By Model Organisms
12.3.3.2.5. By End User
12.3.4. Egypt Transgenic Animal Market Outlook
12.3.4.1. Market Size & Forecast
12.3.4.1.1. By Value
12.3.4.2. Market Share & Forecast
12.3.4.2.1. By Product
12.3.4.2.2. By Technique
12.3.4.2.3. By Application
12.3.4.2.4. By Model Organisms
12.3.4.2.5. By End User
12.3.5. Turkey Transgenic Animal Market Outlook
12.3.5.1. Market Size & Forecast
12.3.5.1.1. By Value
12.3.5.2. Market Share & Forecast
12.3.5.2.1. By Product
12.3.5.2.2. By Technique
12.3.5.2.3. By Application
12.3.5.2.4. By Model Organisms
12.3.5.2.5. By End User
13. MARKET DYNAMICS
13.1. Drivers
13.2. Challenges
14. MARKET TRENDS & DEVELOPMENTS
15. COMPETITIVE LANDSCAPE (INCLUSIVE OF SWOT ANALYSIS)
15.1. Merck & Co., Inc.
15.2. C.H. Boehringer Sohn Ko. KG
15.3. Randox Laboratories Limited
15.4. Zoetis, Inc.
15.5. Virbac SA
15.6. Elanco Animal Health Inc.
15.7. Biogйnesis Bagу SA
15.8. Santa Cruz Biotechnology, Inc
15.9. Idexx Laboratories, Inc.
15.10. Innovative Diagnostics (IDVet)
16. STRATEGIC RECOMMENDATIONS
